Trial Profile
Comparative study of ganetespib and cytarabine in acute myeloid leukemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Ganetespib (Primary) ; Cytarabine
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 09 Dec 2015 New trial record